Pharmaceutical companies continue to face a complex landscape. Geopolitical tensions and the pandemic have disrupted supply chains, and yet expectations for increased speed to market are higher than ever. Findings from a recent study conducted by FT Longitude of 400 experts in drug development and manufacturing, as well as input from professionals at GSK, Roche, Merck KGaA (Darmstadt Germany) and Kashiv BioSciences, reveal where drug manufacturing is headed in the next 3-5 years.

Watch this on-demand webinar with Andrea Corona of Pharma Manufacturing and Chanice Henry, senior editor at FT Longitude to learn about:   

• How pharma companies are prioritizing digital transformation initiatives   
• The evolution in cultural maturity around tech adoption, and where gaps remain – including at the C-suite level     
• Specific recommendations as to how pharma companies can boost operational agility and efficiency     

Discover how forward-thinking pharma companies are taking advantage of data, cultural changes and digital technology to put their companies on the path to success.